Fundz

T2 Biosystems, Inc. reported raising $39.7 Million in an initial SEC Form D filing, from an offering of $39.7 Million

PRIVATESep 27, 2016

Amount Raised

$39.7 Million

$39.7 Million sold, per SEC Form D (first sale Sep 27, 2016)

Round Type

Venture

LexingtonManufacturingBiotechnologyHealthcareHealth Care

Who to call at T2 Biosystems, and when

A new round usually means T2 Biosystems is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day T2 Biosystems raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at T2 Biosystems, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

T2 Biosystems

Location

Lexington, Massachusetts, United States

About

T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, the T2Bacteria® Panel, the T2Candida® Panel, the T2Resistance® Panel, the T2BiothreatTM Panel, and the T2SARS-CoV-2TM Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including the expanded T2Bacteria Panel to add Acinetobacter baumannii, the Candida auris test, and the T2LymeTM Panel, as well as next-generation products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment T2 Biosystems raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts16 people are listed at T2 Biosystems. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for T2 Biosystems's next move

See what Strategic adds

T2 Biosystems raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.